Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
The Long Run with Luke Timmerman
Innovations in RNA Delivery
This chapter explores the strategic decisions of a biotechnology company focusing on antisense oligonucleotide therapies, detailing the speaker's transition to CEO and their innovative use of antibody oligonucleotide conjugates. It emphasizes the importance of scientific data in advancing therapies for muscle diseases and highlights the company's unique approach to RNA technology.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
